TAMARA MCDANIEL: Open Payments
NPI 1154349801 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 37 payments from 7 companies in 2025. Trend: 2023 $268 · 2024 $627 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $218 |
| ABBVIE INC. | 15 | $156 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Lundbeck LLC | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, SPRAVATO, INVEGA SUSTENNA, TRINTELLIX, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
